Variable | Univariable analysis | Multivariable analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
CFRT | 3.23 | 1.65–6.32 | 0.001 | 3.26 | 1.37–7.80 | 0.008 |
Age 50+ | 2.17 | 1.11–4.22 | 0.022 | 0.74 | 0.28–1.96 | 0.543 |
Concurrent chemo | 0.54 | 0.29–1.02 | 0.057 | 0.76 | 0.31–1.88 | 0.550 |
Non-White | 0.97 | 0.53–1.80 | 0.941 | |||
AC or AP use | 0.62 | 0.22–1.77 | 0.373 | |||
Non-cervical primary | 1.20 | 0.62–2.33 | 0.581 | |||
Pre-menopausal | 0.70 | 0.38–1.29 | 0.259 | |||
Transfusion required | 1.14 | 0.60–2.21 | 0.680 | |||
Metastatic | 1.15 | 0.60–2.20 | 0.669 | |||
Recurrence | 3.53 | 1.42–8.82 | 0.007 | 1.96 | 0.51–7.54 | 0.326 |
Prior pelvic RT | 10.50 | 1.17–93.9 | 0.035 | 2.06 | 0.16–27.00 | 0.582 |
Prior pelvic surgery | 1.87 | 0.93–3.77 | 0.080 | 1.76 | 0.68–4.57 | 0.243 |
Prior systemic therapy | 6.12 | 2.30–16.33 | < 0.001 | 2.17 | 0.64–7.28 | 0.211 |
Pretreatment Hgb (continuous) | 0.96 | 0.82–1.12 | 0.597 |